Ventana dismisses Roche bid for fourth time

TUSCON, Ariz. Ventana Medical Systems has once again shot down an offer from Roche, in which the company would acquire all of Ventana’s outstanding shares.

“More than 99.5 percent of our investors have now essentially turned down Roche’s inadequate offer four times, and yet Roche persists with its futile and costly tactics,” said Christopher Gleeson, Ventana’s president and chief executive officer.

“Virtually all of our investors agree with us that $75.00 is a non-starter and they recognize that we are gaining real momentum in our marketplace. We are proud of our people who are continuing to perform extremely well despite the potential for distraction, and we are grateful to our shareholders for their continued support,” continued Gleeson.